Geode Capital Management’s Entera Bio ENTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$52.9K Buy
29,908
+8,772
+42% +$11K ﹤0.01% 4234
2026
Q1
$23.5K Hold
21,136
﹤0.01% 4436
2025
Q4
$41K Hold
21,136
﹤0.01% 4270
2025
Q3
$40.6K Hold
21,136
﹤0.01% 4337
2025
Q2
$40.2K Hold
21,136
﹤0.01% 4258
2025
Q1
$35.9K Hold
21,136
﹤0.01% 4254
2024
Q4
$44.2K Buy
21,136
+3,539
+20% +$6.61K ﹤0.01% 4263
2024
Q3
$33.4K Hold
17,597
﹤0.01% 4339
2024
Q2
$32.4K Hold
17,597
﹤0.01% 4373
2024
Q1
$29.4K Hold
17,597
﹤0.01% 4416
2023
Q4
$10.6K Hold
17,597
﹤0.01% 4582
2023
Q3
$12.8K Hold
17,597
﹤0.01% 4697
2023
Q2
$15K Hold
17,597
﹤0.01% 4690
2023
Q1
$20.4K Hold
17,597
﹤0.01% 4701
2022
Q4
$12K Hold
17,597
﹤0.01% 4825
2022
Q3
$18K Hold
17,597
﹤0.01% 4928
2022
Q2
$23K Hold
17,597
﹤0.01% 4903
2022
Q1
$50K Hold
17,597
﹤0.01% 4801
2021
Q4
$49K Hold
17,597
﹤0.01% 4859
2021
Q3
$82K Hold
17,597
﹤0.01% 4708
2021
Q2
$105K Buy
+17,597
New +$65.1K ﹤0.01% 4545

Other funds holding ENTX

Geode Capital Management's ENTX Position: Q2 2026 in Review

Geode Capital Management increased its Entera Bio (ENTX) stake by 42% in Q2 2026, buying an estimated $11K and bringing the position to 29,908 shares worth $52.9K. The position accounts for ﹤0.01% of the portfolio, ranked #4234.

Geode Capital Management first reported a position in ENTX in Q2 2021 and has held it in 21 quarters since. The position peaked at $105K in Q2 2021. 15 funds tracked by Wall St. Rank hold ENTX as of Q2 2026.

  • Geode Capital Management held 29,908 shares of Entera Bio worth $52.9K as of Q2 2026.
  • Geode Capital Management bought 8,772 Entera Bio shares in Q2 2026, an estimated $11K.
  • Entera Bio made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #4234 holding.
  • Geode Capital Management first reported a position in Entera Bio in Q2 2021 and has held it in 21 quarters since.
  • Geode Capital Management's Entera Bio position peaked at $105K in Q2 2021.
  • 15 funds tracked by Wall St. Rank held Entera Bio as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.